We are live on ! Find out more
Goldman Sachs

Goldman Sachs Portfolio holdings

AUM $871B
1-Year Est. Return 31.28%
 

Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.

This Fund
S&P 500
This Quarter Est. Return
+27.04%
1 Year Est. Return
+31.28%
3 Year Est. Return
+94.73%
5 Year Est. Return
+114.04%
10 Year Est. Return
+505.55%
AUM
$329B
AUM Growth
+$45.5B
Cap. Flow
-$19.5B
Cap. Flow %
-5.91%
Top 10 Hldgs %
19.09%
Holding
5,697
New
507
Increased
1,879
Reduced
2,401
Closed
535

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.38B
2
AGN
Allergan plc
AGN
+$1.33B
3
MSFT icon
Microsoft
MSFT
+$961M
4
QQQ icon
Invesco QQQ Trust
QQQ
+$803M
5
AMZN icon
Amazon
AMZN
+$740M

Sector Composition

Rank Sector Weight
1 Technology 14.8%
2 Healthcare 9.1%
3 Financials 9.05%
4 Consumer Discretionary 8.76%
5 Communication Services 6.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PEX icon
4426
ProShares Global Listed Private Equity ETF
PEX
$11.3M
$392K ﹤0.01%
+15,185
New +$370K
WINA icon
4427
Winmark
WINA
$1.3B
$392K ﹤0.01%
2,292
+150
+7% +$21.9K
JNCE
4428
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$392K ﹤0.01%
56,872
-23,090
-29% -$125K
MBIO icon
4429
Mustang Bio
MBIO
$4.52M
$390K ﹤0.01%
164
+150
+1,071% +$351K
AGS
4430
DELISTED
PlayAGS
AGS
$389K ﹤0.01%
115,092
-296,134
-72% -$1.13M
BLU
4431
DELISTED
BELLUS Health Inc.
BLU
$389K ﹤0.01%
37,840
BOC icon
4432
Boston Omaha
BOC
$438M
$388K ﹤0.01%
24,235
+14,190
+141% +$237K
EPM icon
4433
Evolution Petroleum
EPM
$125M
$387K ﹤0.01%
138,089
-13,790
-9% -$37K
BVH
4434
DELISTED
Bluegreen Vacations Holding Corporation
BVH
$387K ﹤0.01%
30,417
+4,677
+18% +$45.2K
RVLP
4435
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$387K ﹤0.01%
57,410
+32,985
+135% +$161K
IRS
4436
IRSA Inversiones y Representaciones
IRS
$1.26B
$386K ﹤0.01%
123,414
BRG
4437
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
$386K ﹤0.01%
47,837
-21,982
-31% -$146K
MVBF icon
4438
MVB Financial
MVBF
$395M
$385K ﹤0.01%
28,940
+9,169
+46% +$123K
BCBP icon
4439
BCB Bancorp
BCBP
$159M
$383K ﹤0.01%
41,325
-10,399
-20% -$99.6K
RPTX
4440
DELISTED
Repare Therapeutics
RPTX
$383K ﹤0.01%
+12,353
New +$397K
PTVCB
4441
DELISTED
Protective Insurance Corporation Class B Common Stock
PTVCB
$383K ﹤0.01%
25,445
+15,058
+145% +$210K
CECO icon
4442
Ceco Environmental
CECO
$4.04B
$382K ﹤0.01%
57,890
+18,559
+47% +$101K
AVTX icon
4443
Avalo Therapeutics
AVTX
$997M
$378K ﹤0.01%
+51
New +$370K
CWBC
4444
Community West Bancshares
CWBC
$699M
$378K ﹤0.01%
+24,562
New +$340K
FUTY icon
4445
Fidelity MSCI Utilities Index ETF
FUTY
$2.29B
$378K ﹤0.01%
10,363
-35,158
-77% -$1.31M
RSPR icon
4446
Invesco S&P 500 Equal Weight Real Estate ETF
RSPR
$103M
$378K ﹤0.01%
14,537
USVM icon
4447
VictoryShares US Small Mid Cap Value Momentum ETF
USVM
$1.8B
$377K ﹤0.01%
8,279
PAR icon
4448
PAR Technology
PAR
$719M
$376K ﹤0.01%
+12,547
New +$275K
AVEO
4449
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$374K ﹤0.01%
+72,569
New +$458K
CBIO
4450
Crescent Biopharma
CBIO
$586M
$373K ﹤0.01%
994
+34
+4% +$9.63K

Similar funds

Goldman Sachs's Q2 2020 Portfolio in Review

As of Q2 2020, Goldman Sachs held 5,697 positions worth $329B, up 16% from $284B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Goldman Sachs withdrew a net $19.5B in Q2 2020, closing 535 positions and reducing 2,401 holdings. Its most notable exit was Allergan plc, an estimated $1.33B position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Goldman Sachs opened a new position in Goldman Sachs MarketBeta US Equity ETF worth $209M.

  • Goldman Sachs's largest Q2 2020 buy was Goldman Sachs MarketBeta US Equity ETF: 4,910,076 shares worth $209M.
  • Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q2 2020, an estimated $2.58B increase.
  • Goldman Sachs's biggest Q2 2020 reduction was Apple, cutting an estimated $1.38B.
  • Goldman Sachs fully exited Allergan plc in Q2 2020, selling an estimated $1.33B.
  • Goldman Sachs's ten largest holdings make up 19% of its $329B portfolio in Q2 2020.
  • Goldman Sachs opened 507 new positions and closed 535 in Q2 2020.
  • Goldman Sachs's portfolio value rose 16% quarter-over-quarter to $329B.

Based on Goldman Sachs's 13F filing for Q2 2020, filed 12 Aug 2020.